Product Code: ETC6176264 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The ECMO machine market in Australia, specifically under the Centralized Information System (CIS) medical infrastructure, is expanding due to increasing awareness and the demand for advanced life support systems. These machines are vital for patients with severe respiratory or cardiac failure, often in intensive care units. The COVID-19 pandemic accelerated investment in such critical care technologies. Australias strong healthcare infrastructure and growing investments in hospital modernization are likely to continue supporting market growth, though the high cost of ECMO systems remains a barrier for smaller medical institutions.
The Australian market for Cardio-Intensive Support (CIS) ECMO machines is growing due to increased demand from cardiac and respiratory care units, especially post-COVID. Hospitals are expanding their critical care capacity, and ECMO technology is gaining traction for patients with severe respiratory distress and cardiac failure. Technological advancements such as portable ECMO systems and integrated monitoring features are enhancing adoption. Training programs and funding for intensive care upgrades also support market expansion.
The CIS (Cardiopulmonary Intensive Support) extracorporeal membrane oxygenation (ECMO) machine market in Australia is hindered by the high cost of equipment and the need for highly trained personnel to operate them. These machines are typically used in critical care scenarios and require specialized maintenance, limiting their use to well-funded tertiary hospitals. Furthermore, the limited number of patients who qualify for ECMO treatment adds to the challenge of expanding the market. Public and private healthcare funding constraints also affect procurement.
Australias ECMO machine market is ripe for investment due to increasing demand from intensive care units and cardiopulmonary centers. Opportunities include setting up local assembly or maintenance facilities, partnering with hospitals for ECMO fleet upgrades, and investing in portable or AI-integrated ECMO devices. Given the countrys focus on improving regional healthcare accessibility, mobile ECMO units for rural outreach could be a niche but valuable investment.
Government policies regarding healthcare technology, such as the CIS (Cardiopulmonary Intensive Support) ECMO (Extracorporeal Membrane Oxygenation) machine market, focus on funding and accessibility in critical care. Australias public health system, including Medicare, covers ECMO treatments for eligible patients, which is a crucial policy to make this high-cost technology accessible. However, reimbursement for ECMO devices is highly regulated, and public healthcare facilities face budget constraints that impact the availability and procurement of such expensive equipment. Regulatory approvals from the Therapeutic Goods Administration (TGA) also play a significant role in determining how quickly new ECMO devices can enter the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market - Industry Life Cycle |
3.4 Australia CIS Extracorporeal Membrane Oxygenation Machine Market - Porter's Five Forces |
3.5 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.7 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Trends |
6 Australia CIS Extracorporeal Membrane Oxygenation Machine Market, By Types |
6.1 Australia CIS Extracorporeal Membrane Oxygenation Machine Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Pumps, 2021- 2031F |
6.1.4 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Oxygenators, 2021- 2031F |
6.1.5 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Controllers, 2021- 2031F |
6.1.6 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Cannula, 2021- 2031F |
6.1.7 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Accessories, 2021- 2031F |
6.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market, By Modality |
6.2.1 Overview and Analysis |
6.2.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Veno-Arterial, 2021- 2031F |
6.2.3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Veno-Venous, 2021- 2031F |
6.2.4 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Arterio-Venous, 2021- 2031F |
6.3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Cardiac, 2021- 2031F |
6.3.4 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenues & Volume, By Extracorporeal Cardiopulmonary Resuscitation, 2021- 2031F |
7 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Import-Export Trade Statistics |
7.1 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Export to Major Countries |
7.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Imports from Major Countries |
8 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Key Performance Indicators |
9 Australia CIS Extracorporeal Membrane Oxygenation Machine Market - Opportunity Assessment |
9.1 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.3 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia CIS Extracorporeal Membrane Oxygenation Machine Market - Competitive Landscape |
10.1 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Revenue Share, By Companies, 2024 |
10.2 Australia CIS Extracorporeal Membrane Oxygenation Machine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |